145 related articles for article (PubMed ID: 36877518)
21. Outcomes of a universal germline screening program in a community urology practice.
Mendhiratta N; Hauver H; Hatton W; Ostrusky A; Sathe DS; Gurram S; Rice P; Chalfin H
Clin Genet; 2024 May; ():. PubMed ID: 38711401
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.
Moretz C; Byfield SD; Hatchell KE; Dalton J; Onglao PN; Hang L; Hansen P; Radford C; Nielsen SM; Heald B; Munro SB; Nussbaum RL; Esplin ED
JAMA Netw Open; 2022 Oct; 5(10):e2238167. PubMed ID: 36279135
[TBL] [Abstract][Full Text] [Related]
23. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
Yap TA; Ashok A; Stoll J; Mauer E; Nepomuceno VM; Blackwell KL; Garber JE; Meric-Bernstam F
JAMA Netw Open; 2022 May; 5(5):e2213070. PubMed ID: 35594047
[TBL] [Abstract][Full Text] [Related]
25. The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.
Gerido LH; Griggs JJ; Resnicow K; Kidwell KM; Delacroix E; Austin S; Hanson EN; Bacon E; Koeppe E; Goodall S; Demerath M; Rizzo EA; Weiner S; Hawley ST; Uhlmann WR; Roberts JS; Stoffel EM
Trials; 2023 Feb; 24(1):105. PubMed ID: 36765432
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
27. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
Hinshaw JC; Zhao LP; Brimm JE; Payne TH; Hisama FM
J Genet Couns; 2021 Dec; 30(6):1591-1597. PubMed ID: 33881185
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
Jahn A; Rump A; Widmann TJ; Heining C; Horak P; Hutter B; Paramasivam N; Uhrig S; Gieldon L; Drukewitz S; Kübler A; Bermudez M; Hackmann K; Porrmann J; Wagner J; Arlt M; Franke M; Fischer J; Kowalzyk Z; William D; Weth V; Oster S; Fröhlich M; Hüllein J; Valle González C; Kreutzfeldt S; Mock A; Heilig CE; Lipka DB; Möhrmann L; Hanf D; Oleś M; Teleanu V; Allgäuer M; Ruhnke L; Kutz O; Knurr A; Laßmann A; Endris V; Neumann O; Penzel R; Beck K; Richter D; Winter U; Wolf S; Pfütze K; Geörg C; Meißburger B; Buchhalter I; Augustin M; Aulitzky WE; Hohenberger P; Kroiss M; Schirmacher P; Schlenk RF; Keilholz U; Klauschen F; Folprecht G; Bauer S; Siveke JT; Brandts CH; Kindler T; Boerries M; Illert AL; von Bubnoff N; Jost PJ; Metzeler KH; Bitzer M; Schulze-Osthoff K; von Kalle C; Brors B; Stenzinger A; Weichert W; Hübschmann D; Fröhling S; Glimm H; Schröck E; Klink B
Ann Oncol; 2022 Nov; 33(11):1186-1199. PubMed ID: 35988656
[TBL] [Abstract][Full Text] [Related]
29. Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Clark NM; Roberts EA; Fedorenko C; Sun Q; Dubard-Gault M; Handford C; Yung R; Cheng HH; Sham JG; Norquist BM; Flanagan MR
Ann Surg Oncol; 2023 Mar; 30(3):1312-1326. PubMed ID: 36335273
[TBL] [Abstract][Full Text] [Related]
30. Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists.
Murciano-Goroff YR; McCarthy AM; Bristol MN; Groeneveld P; Domchek SM; Motanya UN; Armstrong K
Breast Cancer Res Treat; 2018 Aug; 171(1):173-180. PubMed ID: 29737473
[TBL] [Abstract][Full Text] [Related]
31. Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.
Lertwilaiwittaya P; Roothumnong E; Nakthong P; Dungort P; Meesamarnpong C; Tansa-Nga W; Pongsuktavorn K; Wiboonthanasarn S; Tititumjariya W; Thongnoppakhun W; Chanprasert S; Limwongse C; Pithukpakorn M
Breast Cancer Res Treat; 2021 Jul; 188(1):237-248. PubMed ID: 33649982
[TBL] [Abstract][Full Text] [Related]
32. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
33. Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study.
Ossa Gomez CA; Achatz MI; Hurtado M; Sanabria-Salas MC; Sullcahuaman Y; Chávarri-Guerra Y; Dutil J; Nielsen SM; Esplin ED; Michalski ST; Bristow SL; Hatchell KE; Nussbaum RL; Pineda-Alvarez DE; Ashton-Prolla P
JCO Glob Oncol; 2022 Jul; 8():e2200104. PubMed ID: 35867948
[TBL] [Abstract][Full Text] [Related]
34. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
[TBL] [Abstract][Full Text] [Related]
35. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
36. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
37. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
[TBL] [Abstract][Full Text] [Related]
38. Effect of a Novel Online Group-Coaching Program to Reduce Burnout in Female Resident Physicians: A Randomized Clinical Trial.
Fainstad T; Mann A; Suresh K; Shah P; Dieujuste N; Thurmon K; Jones CD
JAMA Netw Open; 2022 May; 5(5):e2210752. PubMed ID: 35522281
[TBL] [Abstract][Full Text] [Related]
39. Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations.
Ademuyiwa FO; Salyer P; Ma Y; Fisher S; Colditz G; Weilbaecher K; Bierut LJ
Breast Cancer Res Treat; 2019 Nov; 178(1):151-159. PubMed ID: 31325073
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
